Electrochemical therapy of 74 cases of liver cancer.
Ninety-four patients with primary liver cancer have been treated with electrochemical therapy (ECT) in our hospital. Seventy-four cases were followed up for more than one year, 12 cases for less than one year, and 8 cases were lost. Seventy-four cases of stage II and III liver cancer were divided into three groups. Group A received ECT only, group B received ECT plus transcatheter hepatic artery infusion chemotherapy (TAI) and embolisation (IAE) treatment. Group C received ECT plus systemic chemotherapy. The survival rate at 12 months was 58% for group B patients, which was significantly higher than for group A or C patients. We found ECT to be relatively simple and safe. The main side effect is short-time fever after treatment.
Wang
H L
HL
Jinan Airforce Hospital, China.
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004599:Electric Stimulation Therapy / Q000009:adverse effects / Q000379:methods*; D004563:Electrochemistry; D004621:Embolization, Therapeutic; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage; D012074:Remission Induction; D015996:Survival Rate; D013997:Time Factors
D008937:Mitomycins; D004317:Doxorubicin; D005472:Fluorouracil